Cargando…
The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome
BACKGROUND: Drug induced liver injury (DILI) is a rising morbidity amongst patients with COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated for use in the general population, but its utility for causality determination in cohorts of patients with COVID-19 and DILI...
Autores principales: | Naseralallah, Lina Mohammad, Aboujabal, Bodoor Abdallah, Geryo, Nejat Mohamed, Al Boinin, Aisha, Al Hattab, Fatima, Akbar, Raza, Umer, Waseem, Abdul Jabbar, Layla, Danjuma, Mohammed I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436150/ https://www.ncbi.nlm.nih.gov/pubmed/36048762 http://dx.doi.org/10.1371/journal.pone.0268705 |
Ejemplares similares
-
An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2021) -
The effects of thrombocytopenia, type 2 diabetes mellitus, and endothelial dysfunction on clinical outcomes in patients with COVID-19
por: Faisal, Mohanad, et al.
Publicado: (2022) -
Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020) -
Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis
por: Naseralallah, Lina, et al.
Publicado: (2023) -
Intramedullary Osteosclerosis of the Tibia: A Rare Cause of Osteosclerosis to Keep an Eye On
por: Al-Taie, Alaa, et al.
Publicado: (2023)